Suppr超能文献

美国成年人饮食类黄酮摄入量与慢性支气管炎、肺气肿和哮喘的相关性:一项大型全国性横断面研究。

Correlation of dietary flavonoid intake with chronic bronchitis, emphysema, and asthma in U.S. adults: A large, national, cross-sectional study.

机构信息

Department of Gynecological Tumor Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Department of Gastroenterology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

PLoS One. 2024 Oct 21;19(10):e0309310. doi: 10.1371/journal.pone.0309310. eCollection 2024.

Abstract

OBJECTIVE

To explore the relationship between dietary flavonoids and bronchitis, emphysema and asthma.

METHOD

A total of 11743 United States adults were extracted from the National Health and Nutrition Examination Survey (NHANES) in 2007-2008, 2009-2010 and 2017-2018. Of these, 47.7% were male and 52.3% female. Dietary flavonoid intake assessed using FDNNS and 24-hour dietary recall data. Inclusion of demographics (gender, age, education, family income), behavioral factors (BMI, smoking, drinking status, diet), chronic disease information (diabetes, hypertension) as covariates to eliminate confounding. Stepwise logistic regression was used to analyze the association between total dietary flavonoid intake and the risk of chronic respiratory disease. Weighted quantile sum regression (WQS) was used to analyze the association between 29 dietary flavonoids and the risk of chronic respiratory disease. Restricted cubic spline was used to analyze the dose-response relationship between dietary flavonoid intake and risk of chronic respiratory disease.

RESULTS

Stepwise logistic regression results showed that higher flavonoid intake in men was associated with a lower risk of CB and asthma (OR of CB: 0.55(0.31-0.97); OR of asthma: 0.72(0.52-0.99)), and WQS results showed a mixed health effect for total flavonoids and chronic respiratory tract in response to the 29 flavonoid fractions (OR of asthma: 0.97(0.94-0.99); OR of emphysema: 0.95(0.90-0.99)). Glycitein had the highest health contribution of 26.2% for emphysema; Eriodictyol had the highest health contribution of 32.13% for asthma, respectively. The RCS showed a dose-response relationship between flavonoids and respiratory tract health. The maximum dose for ingesting flavonoids to gain respiratory health benefits is 1500 mg/d.

CONCLUSION

Higher dietary flavonoid intake was associated with lower chronic respiratory risk in adult U.S. men. Also 29 dietary flavonoid components have an overall health effect on respiratory health. Glycitein and Eriodictyol may have potential health effects on the respiratory system. 1500 mg/day may be the Tolerable Upper Intake Level of dietary flavonoids for respiratory health in U.S. adults.

摘要

目的

探讨饮食黄酮类化合物与支气管炎、肺气肿和哮喘的关系。

方法

从 2007-2008 年、2009-2010 年和 2017-2018 年的国家健康和营养调查(NHANES)中提取了 11743 名美国成年人的数据。其中,47.7%为男性,52.3%为女性。使用 FDNNS 和 24 小时膳食回顾数据评估饮食黄酮类化合物的摄入量。纳入人口统计学因素(性别、年龄、教育程度、家庭收入)、行为因素(BMI、吸烟、饮酒状况、饮食)、慢性疾病信息(糖尿病、高血压)作为协变量,以消除混杂因素。采用逐步逻辑回归分析总饮食黄酮类化合物摄入与慢性呼吸道疾病风险之间的关系。采用加权分位数总和回归(WQS)分析 29 种饮食黄酮类化合物与慢性呼吸道疾病风险之间的关系。采用限制性三次样条分析饮食黄酮类化合物摄入与慢性呼吸道疾病风险之间的剂量-反应关系。

结果

逐步逻辑回归结果表明,男性黄酮类化合物摄入量较高与 CB 和哮喘的风险降低相关(CB 的 OR:0.55(0.31-0.97);哮喘的 OR:0.72(0.52-0.99)),WQS 结果表明,总黄酮类化合物和慢性呼吸道对 29 种黄酮类化合物分数的反应呈混合健康效应(哮喘的 OR:0.97(0.94-0.99);肺气肿的 OR:0.95(0.90-0.99))。大豆苷原对肺气肿的健康贡献最高,为 26.2%;柚皮苷对哮喘的健康贡献最高,为 32.13%。RCS 显示了黄酮类化合物与呼吸道健康之间的剂量-反应关系。摄入黄酮类化合物以获得呼吸道健康益处的最大剂量为 1500mg/d。

结论

较高的饮食黄酮类化合物摄入量与美国男性慢性呼吸道疾病风险降低相关。此外,29 种饮食黄酮类化合物成分对呼吸道健康具有整体健康影响。大豆苷原和柚皮苷可能对呼吸系统具有潜在的健康影响。1500mg/d 可能是美国成年人呼吸道健康的可耐受最高摄入量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/366a/11493243/cc6aa6413649/pone.0309310.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验